Medical Condition News

RSS

Monash study reveals why older people have reduced immune responses to cancer therapy

It's called the Silver Tsunami - the increased incidence of cancer with aging, combined with the rapidly aging population means that the Australian health system needs to prepare for an onslaught of cancer diagnoses.

20 Jun 2018

Lifestyle intervention could normalize unhealthy behaviors that lead to cancer, chronic disease

Does this sound like someone you know? He or she spends too much time in front of screens, gets little exercise and eats a diet high in fat and low in fruits and vegetables.

19 Jun 2018

Loyola Medicine study: Floppy eyelids linked to sleep apnea

A Loyola Medicine study is providing further evidence that floppy eyelids may be a sign of sleep apnea.

19 Jun 2018

Simple cognitive task after brain injury improves memory function, study finds

Concern is growing about the danger of sports-related concussions and their long-term impact on athletes. But physicians and healthcare providers acknowledge that the science is evolving, leaving questions about rehabilitation and treatment options.

19 Jun 2018

Methadone or buprenorphine associated with reductions in opioid related mortality

A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.

19 Jun 2018

Persistent psychological stress contributes to development and progression of vision loss

Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study now published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and Personalized Medicine.

19 Jun 2018

Scientists discover new mechanism controlling multiple sclerosis risk

While the DNA sequence remains the same throughout a person's life, the expression of the encoded genes may change with time and contribute to disease development in genetically predisposed individuals.

19 Jun 2018

Study finds combined risk of death and developing cancer to be lowest in light drinkers

A new study, led by Dr Andrew Kunzmann, researcher from the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, has found the combined risk of death and developing a number of cancers is lowest in light drinkers, consuming less than one drink per day, and increases with each additional drink per week.

19 Jun 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018

Mayo Clinic researchers find genetic mutations that increase person's risk for pancreatic cancer

Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA.

19 Jun 2018

Low blood levels of vitamin D linked to increased risk of interstitial lung disease

Reviewing medical information gathered on more than 6,000 adults over a 10-year period, Johns Hopkins researchers have found that lower than normal blood levels of vitamin D were linked to increased risk of early signs of interstitial lung disease.

19 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Study finds IV acetaminophen to be no more effective than oral counterpart for colectomy patients

Intravenous acetaminophen is no more effective than oral acetaminophen for patients undergoing colorectal procedures, Mount Sinai researchers report in a first-of-its-kind study.

19 Jun 2018

Gene signature could improve early diagnosis of TB

Researchers have identified a gene signature that could determine whether a person is going to develop TB, months before they show any symptoms.

19 Jun 2018

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Biophysicists have developed a method for modifying the surface of micro- and nanoparticles — tiny structures measuring between a thousandth and a millionth of a millimeter — by covering them with biological molecules. Engineered in this way, the particles can serve as both therapeutic and diagnostic agents, delivering drugs to cancer cells.

19 Jun 2018

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its program to develop a defined bacterial product for ulcerative colitis (UC). Financial details have not been disclosed.

19 Jun 2018

InHealth Technologies becomes exclusive distributor of RENÚ Voice, RENÚ Gel in the United States

InHealth Technologies has announced that it is now the exclusive distributor of RENÚ Voice and RENÚ Gel in the United States.

19 Jun 2018

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Research from the Department of Inflammation Biology, School of Immunology & Microbial Sciences has shown there is an increased risk of disease flare in Rheumatoid Arthritis patients who suffer from depression.

19 Jun 2018

Medical Condition News

Monash study reveals why older people have reduced immune responses to cancer therapy

Lifestyle intervention could normalize unhealthy behaviors that lead to cancer, chronic disease

Loyola Medicine study: Floppy eyelids linked to sleep apnea

Simple cognitive task after brain injury improves memory function, study finds

Methadone or buprenorphine associated with reductions in opioid related mortality

Persistent psychological stress contributes to development and progression of vision loss

Scientists discover new mechanism controlling multiple sclerosis risk

Study finds combined risk of death and developing cancer to be lowest in light drinkers

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

Mayo Clinic researchers find genetic mutations that increase person's risk for pancreatic cancer

Low blood levels of vitamin D linked to increased risk of interstitial lung disease

Clinical trial targets metastatic colorectal cancer with new combination therapy

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Study finds IV acetaminophen to be no more effective than oral counterpart for colectomy patients

Gene signature could improve early diagnosis of TB

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

InHealth Technologies becomes exclusive distributor of RENÚ Voice, RENÚ Gel in the United States

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News